Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus.
Pathogenic circulating vaccine-derived polioviruses (cVDPVs) have become a major obstacle to the successful completion of the global polio eradication program. Most cVDPVs are recombinant between the oral poliovirus vaccine (OPV) and human enterovirus species C (HEV-C). To study the role of HEV-C sequences in the phenotype of cVDPVs, we generated a series of recombinants between a Madagascar cVDPV isolate and its parental OPV type 2 strain. Results indicated that the HEV-C sequences present in this cVDPV contribute to its characteristics, including pathogenicity, suggesting that interspecific recombination contributes to the phenotypic biodiversity of polioviruses and may favor the emergence of cVDPVs.
Riquet
Franck B
FB
Unité de Biologie des Virus Entériques, Institut Pasteur, Paris, France.
Blanchard
Claire
C
Jegouic
Sophie
S
Balanant
Jean
J
Guillot
Sophie
S
Vibet
Marie-Anne
MA
Rakoto-Andrianarivelo
Mala
M
Delpeyroux
Francis
F
D001483:Base Sequence; D045744:Cell Line, Tumor; D018076:DNA, Complementary; D004196:Disease Outbreaks; D030015:Enterovirus C, Human / Q000737:chemistry; D006801:Humans; D007700:Kinetics; D008969:Molecular Sequence Data; D011051:Poliomyelitis / Q000453:epidemiology* / Q000821:virology; D017955:Poliovirus / Q000145:classification / Q000235:genetics / Q000302:isolation & purification* / Q000472:pathogenicity; D011055:Poliovirus Vaccine, Oral / Q000008:administration & dosage*; D011995:Recombination, Genetic; D014614:Vaccines, Synthetic / Q000737:chemistry* / Q000235:genetics; D014779:Virus Replication
D018076:DNA, Complementary; D011055:Poliovirus Vaccine, Oral; D014614:Vaccines, Synthetic